# US 2025/0320472 A1 · Engineered transaminase polypeptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0320472 A1
- Document ID: US20250320472A1
- Status: Published application
- Kind: A1
- Application number: 19/203,721
- Filed: 2025-05-09
- Published: 2025-10-16
- Earliest claimed: 2020-04-10
- Assignees: Codexis, Inc.
- Applicants: Codexis, Inc.
- Inventors: Scott J. Novick; Nikki Dellas
- Web page: https://patentgrep.com/patent/US20250320472A1

## CPC

- C12N 9/1096: {transferring nitrogenous groups (2.6)}
- C12P 17/182: {Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The present disclosure provides engineered transaminase polypeptides useful for the synthesis of chiral amine compounds under industrially relevant conditions. The disclosure also provides polynucleotides encoding the engineered transaminase polypeptides, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases for the production of chiral amine compounds.

## Claims

### Claim 1

An engineered transaminase comprising a polypeptide sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NOS: 8, 366, and/or 650, or a functional fragment thereof, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 8, 366, and/or 650, and wherein the engineered transaminase exhibits an increase in percent conversion of a substrate to a product relative to an engineered transaminase having the amino acid sequence set forth in SEQ ID NO:366.

### Claim 2 (depends on 1)

The engineered transaminase of claim 1, wherein said polypeptide sequence has at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NO: 8, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence at one or more positions selected from 291, 5, 18/23/149/260/383/395/401/416, 18/23/149/383, 18/163/164, 21, 21/163/315/316, 21/163/323/408, 21/408, 23/56/86/149/163/164/383/401/416, 23/86, 23/149/260, 23/149/284/383/395, 23/163/164/383, 23/163/164/401/416, 24, 42, 42/110, 42/187/272, 42/187/324/363/366, 42/187/353, 42/272/291, 42/272/291/363, 42/272/324/363/366, 42/272/363/410, 42/272/410, 42/291/313/363/410, 42/291/363, 42/291/363/366, 42/353, 42/363, 46, 66, 77, 86/149/163/164/383/395/401, 86/149/395, 86/163/164/260/383, 86/383, 107, 110, 110/187, 110/187/253/410, 134, 138, 149/164/260/383/395/401, 149/260/383, 149/416, 163/259/323/408, 163/259/408, 163/315/316, 164/260/401, 164/316/383/401, 167, 186, 187, 187/253/363/366, 187/272/324/363/410, 187/272/363, 187/272/363/366/410, 187/291, 189, 191, 195, 199, 203, 210, 211, 248, 259/307, 260/395/401, 272, 272/353, 272/363/366, 272/410, 277, 305, 309, 315, 342, 343, 351, 354, 358, 361, 362, 363, 363/366, 365, 367, 383, 383/401, 383/416/422, 385, 388, 389, 392, 395, 396, 401, 404, 405, 408, 410, 416, 417, 439, 443, 447, 450, and 451, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 8.

### Claim 3 (depends on 1)

The engineered transaminase of claim 1, wherein said polypeptide sequence has at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NO: 366, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence at one or more positions selected from 291, 24/42/66/291, 24/42/291/362, 24/66/163/191/362/383/388, 24/66/191/199/260/291/351, 24/66/191/199/291, 24/66/191/260/408, 24/66/260/291/383/388/408, 24/66/291/342/383, 24/66/291/365, 24/66/342/365/388/408, 24/77/291, 24/107/163/191/291/351/383/388, 24/107/291/351/365/388, 24/163/351/383, 24/191/291/365, 24/199/260/351/362/383, 24/199/260/362/383/388, 24/260/362/383/388, 24/291, 24/291/342/351/383, 24/291/362/388, 24/291/408, 24/383/388, 24/388, 25, 28, 33, 42/191/408, 42/199/291/383, 42/291/351/362/365/383/388, 42/291/351/362/383/408, 42/291/383/388, 66/82/291/383, 66/163/191/365/383, 66/199/351/383, 66/291, 66/291/362/365/383, 66/291/383/388, 66/383, 77/291, 77/383/388, 86, 107/191/199/365/383/388, 107/191/291/383, 148, 153, 163/291/362/365/383/388, 163/291/383/388, 163/383, 191/199/365/383/388, 191/260/388, 191/291, 191/291/342/362/365, 191/351/383/388, 199/260/383, 199/291, 260, 260/291/365/383/408, 260/365/383, 291/351/383/388, 291/351/383/388/408, 291/362/365, 291/365/388, 291/383, 314, 315, 316, 319, 342/362, 351/383/388, 362, 362/388, 383, 383/388, 396, 397, 405, 406, 413, 419, and 423, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 366.

### Claim 4 (depends on 1)

The engineered transaminase of claim 1, wherein said polypeptide sequence has at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% more sequence identity to SEQ ID NO: 366, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence at one or more positions selected from 24/66/191/199/291, 24/66/291/365, 163/291/362/365/383/388, 163/291/383/388, 191/291/342/362/365, 291, and 291/383, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 366.

### Claim 5 (depends on 1)

The engineered transaminase of claim 1, wherein said polypeptide sequence has at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% more sequence identity to SEQ ID NO: 650, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence at one or more positions selected from 10, 13, 13/24/108/163, 13/24/108/163/311, 13/24/133/199/311, 13/24/163, 13/24/199/311, 13/108, 13/108/199, 13/108/311, 13/199, 13/311, 14, 14/24/108, 14/24/108/133, 14/24/108/199, 14/24/199, 14/108, 14/108/133/311, 14/108/311, 14/311, 24, 24/163, 24/163/199, 35, 72, 73, 78, 95, 101, 108, 108/199, 114, 154, 163, 169, 175/316, 199, 199/311, 226, 293, 311, 316, 382, 383, and 386, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 650.

### Claim 6 (depends on 1)

The engineered transaminase of claim 1, wherein said polypeptide sequence has at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NO: 650, wherein said engineered transaminase comprises at least one substitution or substitution set in said polypeptide sequence at one or more positions selected from 14/108/133/311, 24/163/199, 72, 78, 316, and 383, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 650.

### Claim 7 (depends on 1)

The engineered transaminase of claim 1, wherein said engineered transaminase comprises a polypeptide sequence that is at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% identical to the sequence of at least one engineered transaminase variant set forth in the even numbered sequences of SEQ ID NOS: 642-936.

### Claim 8 (depends on 1)

The engineered transaminase of claim 1, wherein said engineered transaminase comprises a polypeptide sequence set forth in the even numbered sequences of SEQ ID NOS: 642-936.

### Claim 9 (depends on 1)

The engineered transaminase of claim 1, wherein said substrate comprises compound (1).

### Claim 10 (depends on 1)

The engineered transaminase of claim 1, wherein said engineered transaminase exhibits improved thermostability.

### Claim 11 (depends on 1)

The engineered transaminase of claim 1, wherein said engineered transaminase is purified.

### Claim 12 (depends on 1)

A composition comprising the engineered transaminase of claim 1.

### Claim 13 (depends on 1)

A polynucleotide sequence encoding at least one engineered transaminase of claim 1, wherein said polynucleotide sequence comprises at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NOS: 7, 365, and/or 649, and wherein the polynucleotide sequence of said engineered transaminase comprises at least one substitution at one or more positions.

### Claim 14

A polynucleotide sequence encoding at least one engineered transaminase comprising at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity to SEQ ID NOS: 8, 366, and/or 650, or a functional fragment thereof.

### Claim 15 (depends on 14)

The polynucleotide sequence of claim 14, wherein said polynucleotide sequence is operably linked to a control sequence.

### Claim 16 (depends on 14)

The polynucleotide sequence of claim 14, wherein said polynucleotide sequence is codon optimized.

### Claim 17 (depends on 14)

An expression vector comprising at least one polynucleotide sequence of claim 14.

### Claim 18 (depends on 14)

A host cell comprising at least one polynucleotide sequence of claim 14.

### Claim 19 (depends on 18)

A method of producing an engineered transaminase in a host cell, comprising culturing the host cell of claim 18, under suitable conditions, such that at least one engineered transaminase is produced.

### Claim 20 (depends on 19)

The method of claim 19. further comprising the step of purifying said at least one engineered transaminase.
